These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12567482)

  • 1. [Survey of Toxoplasma infection in patients with thyroid diseases].
    Chen XL; Wang HR; Wang CY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(1):59. PubMed ID: 12567482
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxoplasma gondii antibodies in Mexican blood donors.
    Galván Ramirez ML; Covarrubias X; Rodríguez R; Troyo R; Alfaro N; Correa D
    Transfusion; 2005 Feb; 45(2):281-2. PubMed ID: 15660841
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroprevalence of Toxoplasma gondii in Nazaret town, Ethiopia.
    Negash T; Tilahun G; Medhin G
    East Afr J Public Health; 2008 Dec; 5(3):211-4. PubMed ID: 19374326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiological study of toxoplasmosis in different sections of population of Union Territory of Chandigarh.
    Mohan B; Dubey ML; Malla N; Kumar R
    J Commun Dis; 2002 Mar; 34(1):15-22. PubMed ID: 12718337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survey of toxoplasma infection in fertile age women and children in Urumqi city].
    Ouyang X; Deng X
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):317. PubMed ID: 12563872
    [No Abstract]   [Full Text] [Related]  

  • 6. Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years.
    Diza E; Frantzidou F; Souliou E; Arvanitidou M; Gioula G; Antoniadis A
    Clin Microbiol Infect; 2005 Sep; 11(9):719-23. PubMed ID: 16104986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seroepidemiology of toxoplasmosis in a Yucpa Amerindian community of Sierra de Perijá, Zulia State, Venezuela].
    Díaz-Suárez O; Estévez J; García M; Cheng-Ng R; Araujo J; García M
    Rev Med Chil; 2003 Sep; 131(9):1003-10. PubMed ID: 14635587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade.
    Jones JL; Kruszon-Moran D; Sanders-Lewis K; Wilson M
    Am J Trop Med Hyg; 2007 Sep; 77(3):405-10. PubMed ID: 17827351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of Toxoplasma infection in a metropolitan region of Brazil.
    Fernandes GC; Azevedo RS; Amaku M; Yu AL; Massad E
    Epidemiol Infect; 2009 Dec; 137(12):1809-15. PubMed ID: 19470195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of anti-Toxoplasma gondii antibodies in immunodeficient patients].
    Wang BL; Pan XZ; Yin YK; Weng XH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(4):224-6. PubMed ID: 12567666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary assessment of prevalence of toxoplasmosis in patients with chest diseases.
    el-Shennawy SF
    J Egypt Soc Parasitol; 1991 Dec; 21(3):757-63. PubMed ID: 1765688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A community-based survey of human toxoplasmosis in rural Amazonia: seroprevalence, seroconversion rate, and associated risk factors.
    Ferreira MU; Hiramoto RM; Aureliano DP; da Silva-Nunes M; da Silva NS; Malafronte RS; Muniz PT
    Am J Trop Med Hyg; 2009 Jul; 81(1):171-6. PubMed ID: 19556584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Toxoplasma gondii antibodies in patients infected with hepatitis B virus.
    Ustun S; Aksoy U; Ersoz G; Yazar S; Kilic E
    Saudi Med J; 2005 Jan; 26(1):155-7. PubMed ID: 15756381
    [No Abstract]   [Full Text] [Related]  

  • 14. Seroprevalence of Toxoplasma gondii infection in Kwal, a rural distriction of Plateau-Nigeria.
    Uneke CJ; Duhlinska DD; Ngwu BA; Njoku MO
    Afr J Med Med Sci; 2007 Jun; 36(2):109-13. PubMed ID: 19205571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of acquired toxoplasmosis in HIV-infected and apparently healthy individuals in Jos, Nigeria.
    Uneke CJ; Duhlinska DD; Njoku MO; Ngwu BA
    Parassitologia; 2005 Jun; 47(2):233-6. PubMed ID: 16252478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-toxoplasma Gondii antibodies in Turkish blood donors.
    Yazar S; Eser B; Yay M
    Ethiop Med J; 2006 Jul; 44(3):257-61. PubMed ID: 17447392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Toxoplasma gondii antibodies in hemodialysis patients receiving long-term hemodialysis therapy in Turkey.
    Ocak S; Duran N; Eskiocak AF; Aytac H
    Saudi Med J; 2005 Sep; 26(9):1378-82. PubMed ID: 16155651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasma gondii antibodies in cancer patients.
    Yuan Z; Gao S; Liu Q; Xia X; Liu X; Liu B; Hu R
    Cancer Lett; 2007 Aug; 254(1):71-4. PubMed ID: 17376590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological and clinicoimmunological monitoring of toxoplasmosis in the Omsk Region].
    Dolgikh TI; Zapariĭ NS; Kadtsyna TV; Kalitin AV
    Med Parazitol (Mosk); 2008; (1):19-22. PubMed ID: 18365468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy.
    De Paschale M; Agrappi C; Clerici P; Mirri P; Manco MT; Cavallari S; Viganò EF
    Clin Microbiol Infect; 2008 Feb; 14(2):186-9. PubMed ID: 18034857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.